about
Osteoporosis: the current status of mesenchymal stem cell-based therapy.High insulin levels in KK-Ay diabetic mice cause increased cortical bone mass and impaired trabecular micro-structure.Osteoblastic NF-κB pathway is involved in 1α, 25(OH)2D3-induced osteoclast-like cells formation in vitro.Elevated Serum Uric Acid Is Associated with Greater Bone Mineral Density and Skeletal Muscle Mass in Middle-Aged and Older Adults.Osteoimmunology: from mice to humansEvidence for Altered Canonical Wnt Signaling in the Trabecular Bone of Elderly Postmenopausal Women with Fragility Femoral Fracture.Featured Article: Transcriptional landscape analysis identifies differently expressed genes involved in follicle-stimulating hormone induced postmenopausal osteoporosisTenuigenin promotes the osteogenic differentiation of bone mesenchymal stem cells in vitro and in vivoAppropriate models for novel osteoporosis drug discovery and future perspectives.MicroRNAs in bone development and their diagnostic and therapeutic potentials in osteoporosis.Effects of Osteoglycin (OGN) on treating senile osteoporosis by regulating MSCs.Identifying potentially common genes between dyslipidemia and osteoporosis using novel analytical approaches.Treatment with intermittent PTH increases Wnt10b production by T cells in osteoporotic patients.Sclerostin antibody preserves the morphology and structure of osteocytes and blocks the severe skeletal deterioration after motor-complete spinal cord injury in rats.
P2860
Q33631498-226365CB-7A68-4C73-B3EC-2095BE7877C2Q35585640-8A4A00F4-F26C-46F5-8DAC-9DB5CF6E5BEFQ35854504-F1FF7536-1814-439F-9E3C-430E9A08F087Q36868814-DF853595-628D-4F9B-BBD0-CBA797CB6EF0Q36911794-E74CC3F6-9E5A-4018-B46C-9F579A53AEB7Q37483220-22A7DB46-922A-45BE-B315-5B54ED57D177Q37514781-C5924802-49FE-4B08-92D6-78D2BB540F95Q37609123-568FB446-3271-48A2-A3E8-44DD9C039F4CQ38570326-8C72A45B-786E-433E-A4DA-778B161A8889Q38768325-D5E6D6D1-890E-4753-87D0-7530475266DCQ46327324-1ADEFB63-D4E7-4286-8E66-CD9D8A2EBBECQ50073205-B3E2A227-5EFB-4817-B6FD-3E3FADD5F1D2Q53469719-3296E423-8839-4E84-9531-11D9FA3D015BQ53507211-D0F34BD7-BBA1-4D4B-AFF5-022DFCB638C5
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Wnt signaling and osteoporosis.
@ast
Wnt signaling and osteoporosis.
@en
type
label
Wnt signaling and osteoporosis.
@ast
Wnt signaling and osteoporosis.
@en
prefLabel
Wnt signaling and osteoporosis.
@ast
Wnt signaling and osteoporosis.
@en
P2860
P1433
P1476
Wnt signaling and osteoporosis.
@en
P2093
Stavros C Manolagas
P2860
P304
P356
10.1016/J.MATURITAS.2014.04.013
P577
2014-04-24T00:00:00Z